Clinical Trial Update: A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating Tomudex (raltitrexed) in combination with Iressa (gefitinib) as second-line chemotherapy for colorectal cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Iressa (gefitinib)
• Tomudex (ZD1694)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: COMPLETED